CNXC - NASDAQ
Concentrix Corporation
$27.68
-7.8%Concentrix Corporation provides technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services. It also offers customer lifecycle management; customer experience/user experience strategy and design; digital transformation; and voice of the customer and analytics solutions. The company's clients include consumer electronics, technology, e-commerce, and health insurance companies, as well as global IPOs, social brands, and banks. Concentrix Corporation was incorporated in 2009 and is based in Fremont, California.
At a Glance
Live Snapshotcnxc
Cash and Cash Equivalents
Last Annual Value
327.35M
3-Year CAGR
28%
5-Year CAGR
16%
10-Year CAGR
10%
Concentrix Corporation Competitors Analysis of Cash and Cash Equivalents
| Company | Cash and Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Concentrix Corporation NASDAQ:CNXC | 327.35M | -14.1% | 12.3% | N/A | |
 Globant S.A. NYSE:GLOB | 243.74M | -7.4% | -10.6% | 17.0% | |
 ASGN Incorporated NYSE:ASGN | 102.30M | -16.5% | -28.0% | 14.2% | |
 BigBear.ai Holdings, Inc. NYSE:BBAI | 87.13M | 38.8% | 4.8% | N/A | |
 C3.ai, Inc. NYSE:AI | 164.36M | -16.7% | 7.3% | N/A | |
 DXC Technology Company NYSE:DXC | 1.80B | -1.1% | -7.6% | 4.3% | |
 Innodata Inc. NASDAQ:INOD | 82.23M | 81.3% | 34.2% | 19.2% |
Concentrix Corporation Fair Value Envelope
Related Guides
Continue your CNXC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.